Media Centre
Latest press releases
-
Alexion advances pioneering leadership in gMG care with data at 2026 AANEM Annual Meeting and MGFA Scientific Session
-
AstraZeneca expands company’s $100m+ commitment to advance youth health equity in more than 60 countries
-
Trixeo approved in the EU for the maintenance treatment of asthma
-
Klygefa (gefurulimab) recommended for approval in the EU by CHMP for the treatment of adults with generalised myasthenia gravis (gMG)
-
Enhertu recommended for approval in the EU by CHMP as adjuvant treatment for patients with residual disease after neoadjuvant treatment for HER2-positive early breast cancer
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
